Increased obesity leads to decreased levels of adiponectinresulting in insulin resistance, improper functions of thyroid gland in Met S patients [15].Therefore, it is of interest to analyse the Correlation of serum adiponectin with thyroid profile in metabolic syndrome patients withand without hypothyroidism. Here, ADIPOQ is linked to metabolic syndrome.